Evonik Degussa GmbH manufactures specialty chemicals. It operates in three segments: Technology Specialties, Consumer Solutions, and Specialty Materials. The Technology Specialties segment produces alkoxides, alkyl chlorides, pyrimidines, cyanamide, dicyandiamide, cyanuric chloride, cyanoacetates, malonates, ortho esters, NCN derivatives, phenolic antioxidants, and triacetoneamine derivatives, as well as specialty building blocks; adhesives and sealants, and additives; organic peroxides, persulphates, and organic intermediates; and heterogeneous, homogeneous, and biocatalysts. This segment’s products also include butadiene, 1-butene, isononano l, and the plasticizer DINP; and aerosil and sil...
Rodenbacher Chaussee 4
Founded in 1873
49 6181 59 12532
49 6181 59 4489
Evonik Degussa GmbH Presents at World Congress on Industrial Biotechnology, May-12-2014
May 9 14
Evonik Degussa GmbH Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.
Daimler Mulls Options For Li-Tec Battery
Jun 10 13
Daimler AG (XTRA:DAI) is reviewing options for its Li-Tec Battery GmbH, a joint venture with Evonik Degussa GmbH. The options also include bringing in a new partner. Silke Walters, Spokeswoman for Daimler, said Daimler intends to give the Li-Tec venture a broader footing in the challenging battery-cell market, however, no decision has been made. Also, Evonik’s Spokeswoman Barbara Mueller said the review may lead to bringing a new strategic partner on board. Also the Wall Street Journal reported, citing unidentified sources that the partners were mulling a sale of the joint venture and were looking for a price of about €1 billion.